Gordon Scott has been an active investor and technical analyst for 20+ years. He is a Chartered Market Technician (CMT). Skylar Clarine is a fact-checker and expert in personal finance with a range of ...
8d
Recursion outlines $375M 2026 cash OpEx guidance while advancing first Genentech neuroscience target
We are no longer just discussing the potential of our platform." (CEO, President & Director Najat Khan) "We now have 5 clinical stage programs, including REC-4881 in FAP, where we have generated some ...
Gordon Scott has been an active investor and technical analyst for 20+ years. He is a Chartered Market Technician (CMT). Katrina Ávila Munichiello is an experienced editor, writer, fact-checker, and ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results